• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾小管细胞在法布里肾病发病机制中的作用。

The role of tubular cells in the pathogenesis of Fabry nephropathy.

作者信息

Rozenfeld Paula, Feriozzi Sandro, Braun Fabian

机构信息

Instituto de Estudios Inmunológicos y Fisiopatológicos (IIFP), UNLP, CONICET, Asociado CIC PBA, Facultad de Ciencias Exactas, La Plata, Argentina.

Nephrology and Dialysis Unit, Belcolle Hospital, Viterbo, Italy.

出版信息

Front Cardiovasc Med. 2024 Apr 5;11:1386042. doi: 10.3389/fcvm.2024.1386042. eCollection 2024.

DOI:10.3389/fcvm.2024.1386042
PMID:38646152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11027898/
Abstract

The pathophysiology of Fabry nephropathy (FN) is induced by galactosidase A deficiency with a chronic exposure of glycolipids to every lineage of renal cells. Tissue damage is attributed to the activation of molecular pathways, resulting in tissue fibrosis and chronic kidney disease. Podocytes have been the primary focus in clinical pathophysiological research because of the striking accumulation of large glycolipid deposits observable in histology. Yet, the tubular interstitium makes up a large portion of the whole organ, and therefore, its role must be further considered in pathogenic processes. In this review, we would like to propose Fabry tubulopathy and its ensuing functional effects as the first pathological signs and contributing factors to the development of FN. We will summarize and discuss the current literature regarding the role of tubular cells in Fabry kidney pathophysiology. Starting from clinical and histological evidence, we will highlight the data from animal models and cell cultures outlining the pathophysiological pathways associated with tubular interstitial injury causing renal fibrosis in Fabry nephropathy.

摘要

法布里肾病(FN)的病理生理学是由α-半乳糖苷酶A缺乏引起的,糖脂长期暴露于肾细胞的各个谱系。组织损伤归因于分子途径的激活,导致组织纤维化和慢性肾病。由于在组织学上可观察到大量糖脂沉积物的显著积累,足细胞一直是临床病理生理学研究的主要焦点。然而,肾小管间质占整个器官的很大一部分,因此,其在致病过程中的作用必须进一步加以考虑。在本综述中,我们提出法布里肾小管病及其随后的功能影响作为FN发展的首个病理体征和促成因素。我们将总结并讨论目前关于肾小管细胞在法布里肾病病理生理学中作用的文献。从临床和组织学证据出发,我们将重点介绍动物模型和细胞培养的数据,概述与导致法布里肾病肾纤维化的肾小管间质损伤相关的病理生理途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b6/11027898/ec7b580598d7/fcvm-11-1386042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b6/11027898/ec7b580598d7/fcvm-11-1386042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b6/11027898/ec7b580598d7/fcvm-11-1386042-g001.jpg

相似文献

1
The role of tubular cells in the pathogenesis of Fabry nephropathy.肾小管细胞在法布里肾病发病机制中的作用。
Front Cardiovasc Med. 2024 Apr 5;11:1386042. doi: 10.3389/fcvm.2024.1386042. eCollection 2024.
2
Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis.法布里肾病的发病机制:纤维化的途径。
Mol Genet Metab. 2020 Feb;129(2):132-141. doi: 10.1016/j.ymgme.2019.10.010. Epub 2019 Oct 30.
3
Anderson-Fabry disease: a multiorgan disease.安德森-法布里病:一种多系统疾病。
Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352.
4
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).法布瑞氏病肾脏病理记分系统:国际法布瑞氏肾病研究组(ISGFN)报告。
Nephrol Dial Transplant. 2010 Jul;25(7):2168-77. doi: 10.1093/ndt/gfp528. Epub 2009 Oct 15.
5
Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.长期酶替代疗法可减少 Fabry 病女性患者的蛋白尿并保护近端肾小管功能。
Nephrol Dial Transplant. 2014 Mar;29(3):619-25. doi: 10.1093/ndt/gft452. Epub 2013 Nov 8.
6
Pathology and pathogenic pathways in fabry nephropathy.法布里肾病的病理学和发病机制途径。
Clin Exp Nephrol. 2021 Sep;25(9):925-934. doi: 10.1007/s10157-021-02058-z. Epub 2021 Mar 26.
7
Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.免疫组织化学诊断法在石蜡包埋肾组织切片中对法布里肾病的诊断及糖鞘脂沉积的定位。
Virchows Arch. 2012 Feb;460(2):211-21. doi: 10.1007/s00428-011-1182-y. Epub 2011 Dec 29.
8
Kidney histologic alterations in α-Galactosidase-deficient mice.α-半乳糖苷酶缺乏小鼠的肾脏组织学改变。
Virchows Arch. 2011 Apr;458(4):477-86. doi: 10.1007/s00428-011-1051-8. Epub 2011 Feb 16.
9
Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy.2,8-二羟腺嘌呤肾病中肾损伤的细胞和分子机制。
J Am Soc Nephrol. 2020 Apr;31(4):799-816. doi: 10.1681/ASN.2019080827. Epub 2020 Feb 21.
10
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.神经酰胺三己糖苷对人肾小球足细胞的作用:对法布里肾病的启示。
Nephrol Dial Transplant. 2011 Jun;26(6):1797-802. doi: 10.1093/ndt/gfq306. Epub 2010 May 26.

引用本文的文献

1
Urine-derived renal epithelial cells for deep phenotyping and transcriptomic response to therapy in Fabry disease.用于法布里病深度表型分析及治疗转录组反应的尿液来源肾上皮细胞
Clin Sci (Lond). 2025 Jul 28;139(14):791-808. doi: 10.1042/CS20255570.
2
Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes.固有免疫反应在肾小球疾病发病机制中的作用:聚焦于足细胞。
Cells. 2024 Jul 6;13(13):1157. doi: 10.3390/cells13131157.

本文引用的文献

1
Complement activation and cellular inflammation in Fabry disease patients despite enzyme replacement therapy.尽管进行了酶替代疗法,法布病患者仍存在补体激活和细胞炎症。
Front Immunol. 2024 Jan 18;15:1307558. doi: 10.3389/fimmu.2024.1307558. eCollection 2024.
2
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy.α-突触核蛋白的积累介导法布里肾病中的足细胞损伤。
J Clin Invest. 2023 Jun 1;133(11):e157782. doi: 10.1172/JCI157782.
3
Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease.
在经典法布里病小鼠模型中,Globotriaosylceramide和Globotriaosylsphingosine的独特蓄积。
Mol Genet Metab Rep. 2023 Jan 2;34:100952. doi: 10.1016/j.ymgmr.2022.100952. eCollection 2023 Mar.
4
α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response.与法布里病相关的α-半乳糖苷酶A错义变体可导致内质网应激并诱导未折叠蛋白反应。
Mol Genet Metab Rep. 2022 Oct 31;33:100926. doi: 10.1016/j.ymgmr.2022.100926. eCollection 2022 Dec.
5
The fibrogenic niche in kidney fibrosis: components and mechanisms.肾脏纤维化中的纤维生成龛:组成成分和机制。
Nat Rev Nephrol. 2022 Sep;18(9):545-557. doi: 10.1038/s41581-022-00590-z. Epub 2022 Jul 4.
6
Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.阿帕他胺通过抑制表观遗传读蛋白,抑制接受酶替代疗法的法布雷病患者激活的先天免疫细胞中的炎症反应。
Pharmacol Res Perspect. 2022 Jun;10(3):e00949. doi: 10.1002/prp2.949.
7
Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease.铈锆纳米粒子通过增强法布里病细胞和动物模型中的自噬通量,减少细胞内神经节苷脂 GM3 的积累并减轻肾脏损伤。
J Nanobiotechnology. 2022 Mar 9;20(1):125. doi: 10.1186/s12951-022-01318-8.
8
Reduced α-galactosidase A activity in zebrafish ( mirrors distinct features of Fabry nephropathy phenotype.斑马鱼中α-半乳糖苷酶A活性降低(反映了法布里肾病表型的独特特征)。 (注:括号内为补充完整语义后的内容,原文括号缺失)
Mol Genet Metab Rep. 2022 Feb 17;31:100851. doi: 10.1016/j.ymgmr.2022.100851. eCollection 2022 Jun.
9
Kidney and heart failure outcomes associated with SGLT2 inhibitor use.与 SGLT2 抑制剂使用相关的肾脏和心力衰竭结局。
Nat Rev Nephrol. 2022 May;18(5):294-306. doi: 10.1038/s41581-022-00535-6. Epub 2022 Feb 10.
10
Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation.法布里病中的血管内皮功能障碍与糖萼降解有关。
Front Immunol. 2021 Nov 30;12:789142. doi: 10.3389/fimmu.2021.789142. eCollection 2021.